Filtered By:
Management: Centers for Disease Control and Prevention (CDC)
This page shows you your search results in order of date. This is page number 3.
Order by Relevance | Date
Total 231 results found since Jan 2013.
The Current COVID-19 Booster-Shot Strategy is Not Sustainable, Says FDA ’s Expert Panel
While the currently available COVID-19 vaccines remain effective in protecting people from serious disease, public health experts still face a handful of important questions about the shots and their ability to continue to protect against the virus in coming years. Will a new version of the vaccine be more effective? How long does protection last? Are boosters the only way to extend that protection? Is there a better, more coordinated way to give vaccines and boosters to maximize immunity in the face of an ever-changing virus?
Those were the discussion topics that the U.S. Food and Drug Administration’s Vaccines and ...
Source: TIME: Health - April 7, 2022 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
Rapid progress in our understanding of COVID-19 vaccine allergy: A cause for optimism, not hesitancy
Anaphylaxis is a life-threatening condition and when associated with vaccination, leads to vaccine hesitancy. The concerns around vaccine-related anaphylaxis have become even more important during the coronavirus disease 2019 (COVID-19) pandemic where the COVID-19 vaccines remain one of our most important tools. Although rates of anaphylaxis to COVID-19 vaccines are not significantly different from those to other vaccines, Centers for Disease Control and Prevention guidance recommends avoidance of the same COVID-19 vaccine in individuals who had an allergic reaction or are allergic to a COVID-19 vaccine component.
Source: Journal of Allergy and Clinical Immunology - April 7, 2022 Category: Allergy & Immunology Authors: Aleena Banerji, Allison E. Norton, Kimberly G. Blumenthal, Cosby A. Stone, Elizabeth Phillips Tags: Rostra Source Type: research
With All Eyes on BA.2, Here ’s What Experts Say Might Happen in the U.S.
For the last two years, the U.S. has been stuck in a cycle of COVID-19 case spikes and lulls. Cases rise dramatically, then drop off—and the process repeats.
Several times, these surges have been preceded by rising case rates in Europe—such as before last year’s Delta wave and the start of last winter’s Omicron spike—which is why experts have been carefully monitoring a recent increase in cases there. More than 5.2 million COVID-19 infections were reported across Europe during the week ending March 20, according to World Health Organization data, and countries including the U.K. have also repo...
Source: TIME: Health - March 25, 2022 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
With All Eyes on BA.2, Here ’ s What Experts Say Might Happen in the U.S.
For the last two years, the U.S. has been stuck in a cycle of COVID-19 case spikes and lulls. Cases rise dramatically, then drop off—and the process repeats.
Several times, these surges have been preceded by rising case rates in Europe—such as before last year’s Delta wave and the start of last winter’s Omicron spike—which is why experts have been carefully monitoring a recent increase in cases there. More than 5.2 million COVID-19 infections were reported across Europe during the week ending March 20, according to World Health Organization data, and countries including the U.K. have also repo...
Source: TIME: Health - March 25, 2022 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
What to Know About a Fourth COVID-19 Vaccine Dose
Most people ages 12 and older are considered “up to date” with their COVID-19 vaccines if they received either three doses of the mRNA shots from Pfizer-BioNTech or Moderna, or two doses of Johnson & Johnson’s Janssen vaccine. But some public health experts say another dose might be needed in the coming months.
The Washington Post reports today that Pfizer and BioNTech soon plan to request authorization from the U.S. Food and Drug Administration (FDA) for a fourth dose of their vaccine in people ages 65 and older. In the past few days, Albert Bourla, Pfizer’s CEO, has said that he believes every...
Source: TIME: Health - March 15, 2022 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
Trends in Food Allergy Research, Regulations and Patient Care
This review provides an overview of food allergies, their impact on affected individuals and caregivers, regulatory activities, and current research efforts to improve allergen management and patient care. Food allergies have been reported to affect up to 32 million Americans, including approximately 6 million children. The Centers for Disease Control and Prevention reported that food allergies in children have clearly increased by 50% between 1997 and 2011. Recent years have seen significant advances in the understanding of responses to food allergens such as the development of response thresholds that hold promise for de...
Source: Nutrition Today - March 1, 2022 Category: Nutrition Tags: Nutrition and Communications Source Type: research
A Pediatric Asthma Camp Experience during the COVID-19 Pandemic
Every year, Camp Wheez is offered as a free summer day camp for children with asthma. Because of the ongoing coronavirus disease of 2019 (COVID-19) pandemic, Camp Wheez 2020 was canceled. For 2021, we adapted Camp Wheez to the guidelines for summer camps put forth by the Centers for Disease Control and Prevention (CDC).1
Source: Annals of Allergy, Asthma and Immunology - February 3, 2022 Category: Allergy & Immunology Authors: Victoria Eng, Gary Paul Moreno, Jinny Chang, Myron Liebhaber Tags: Letters Source Type: research
A pediatric asthma camp experience during the coronavirus disease 2019 pandemic
Every year, Camp Wheez is offered as a free summer day camp for children with asthma. Because of the ongoing coronavirus disease 2019 (COVID-19) pandemic, Camp Wheez 2020 was canceled. For 2021, we adapted Camp Wheez to the guidelines for summer camps put forth by the Centers for Disease Control and Prevention.1
Source: Annals of Allergy, Asthma and Immunology - February 3, 2022 Category: Allergy & Immunology Authors: Victoria Eng, Gary Paul Moreno, Jinny Chang, Myron Liebhaber Tags: Letters Source Type: research
U.S. Government Recommends Americans Get the Pfizer-BioNTech or Moderna COVID-19 Shots Instead of J & J ’s
Most Americans should be given the Pfizer or Moderna vaccines instead of the Johnson & Johnson shot that can cause rare but serious blood clots, U.S. health advisers recommended Thursday.
The strange clotting problem has caused nine confirmed deaths after J&J vaccinations — while the Pfizer and Moderna vaccines don’t come with that risk and also appear more effective, advisers to the Centers for Disease Control and Prevention said.
It’s an unusual move and the CDC’s director, Dr. Rochelle Walensky, must decide whether to accept the panel’s advice.
Until now the U.S. has treated all thr...
Source: TIME: Health - December 17, 2021 Category: Consumer Health News Authors: LAURAN NEERGAARD and MIKE STOBBE / AP Tags: Uncategorized COVID-19 healthscienceclimate wire Source Type: news
Johnson & Johnson Announces Positive CHMP Opinion for a Booster Shot of its COVID-19 Vaccine
NEW BRUNSWICK, N.J., December 15, 2021 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a Positive Opinion for use of the Company’s COVID-19 vaccine as a booster for adults aged 18 and older at least two months after primary vaccination with a single-shot of the Johnson & Johnson COVID-19 vaccine, and as a ‘mix and match’ booster following primary vaccination with an approved two-shot mRNA COVID-19 vaccine regimen (known as heterologous boosting). “We are pleased with today’s Positiv...
Source: Johnson and Johnson - December 15, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
FDA Authorizes COVID-19 Vaccine for Children 5-11 Years Old
COVID-19 vaccines are already authorized for children ages 12 and older, and the shots now have the backing of U.S. Food and Drug Administration (FDA) for younger children ages 5 to 11.
On Oct. 29, the FDA authorized the COVID-19 vaccine made by Pfizer-BioNTech for the youngest eligible group yet to get immunized against the disease in the US. The decision followed the recommendation from the agency’s advisory committee, which concluded in a 17 to 0 vote, with one abstention, that the vaccine was safe and effective in younger kids. For these children, the FDA is recommending a two-dose regimen at one-third the dosage...
Source: TIME: Health - October 26, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
FDA Committee Recommends COVID-19 Vaccine for Children 5-11 Years Old
COVID-19 vaccines are already authorized for children ages 12 and older, and the shots now have the support of a U.S. Food and Drug Administration (FDA) expert panel for younger children ages 5 to 11.
In a 17 to 0 vote, with one abstention, the committee recommended the COVID-19 vaccine made by Pfizer-BioNTech for the youngest group yet to potentially get immunized against the disease in the US. The committee recommended a two-dose regimen at one-third the dosage approved for adults.
The FDA now takes the committee’s advice into consideration before making a final recommendation. If the agency decides to recommend th...
Source: TIME: Health - October 26, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news
CDC Authorizes Boosters of Moderna and Johnson & Johnson COVID-19 Vaccines
Dr. Rochelle Walensky, director of the Centers for Disease Control and Prevention (CDC), authorized booster doses of COVID-19 vaccines for certain groups. Walensky followed the advice of a CDC expert panel, which recommended the boosters in in two unanimous votes earlier in the day.
The 15-member Advisory Committee on Immunization Practices (ACIP) advised that anyone who was initially vaccinated with the Moderna shot get a booster at least six months later, and that J&J-Janssen recipients receive a booster at least two months after their initial vaccination. The endorsement follows a similar decision from the Food and ...
Source: TIME: Health - October 21, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news
CDC Authorizes Boosters of Moderna and Johnson & Johnson COVID-19 Vaccines
Dr. Rochelle Walensky, director of the Centers for Disease Control and Prevention (CDC), authorized booster doses of COVID-19 vaccines for certain groups. Walensky followed the advice of a CDC expert panel, which recommended the boosters in in two unanimous votes earlier in the day.
The 15-member Advisory Committee on Immunization Practices (ACIP) advised that anyone who was initially vaccinated with the Moderna shot get a booster at least six months later, and that J&J-Janssen recipients receive a booster at least two months after their initial vaccination. The endorsement follows a similar decision from the Food and ...
Source: TIME: Health - October 21, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news
The CDC Turns Its Back on Migrants and Science
Credit: UNOHCR.By Jamile Tellez Lieberman and Joe AmonPHILADELPHIA, US, Oct 7 2021 (IPS) Last month, asylum-seeking families at the U.S.-Mexico border appeared to have won a victory, however temporary, in their last-ditch bid for safety in the United States. It was also a victory for evidence-based public health policy.
The 1,954-mile-long southern border has always been a magnet for debate, with deep political divides. Bolstered by Donald Trump during his presidency, long-simmering anti-immigrant rhetoric and xenophobia surrounding migration and immigration increased dramatically.
Starting in 2016, under the previous admi...
Source: IPS Inter Press Service - Health - October 7, 2021 Category: International Medicine & Public Health Authors: Jamile Tellez Lieberman and Joe Amon Tags: Headlines Health Human Rights Migration & Refugees North America TerraViva United Nations Source Type: news
